PFLPhysiological Fitness Landscape

Biomarkers · Aging & Senescence

Leukocyte Telomere Length

Higher values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).

Leukocyte Telomere Length and risk of death

Published curve higher than the NHANES fitNHANES fit higher

Risk of death relative to the curve's reference value, drawn from the published study (source below).

Published risk of death1.09×per 1 SD decrement in leukocyte telomere length (95% CI 1.06–1.13) · Meta-analysis of 25 studies (4 Swedish Twin Registry cohorts + 21 published studies), 121,749 individuals

What studies found when this marker was changed

They describe what happened in those study groups, not a recommendation. See all catalogued interventions.

Measured changes in Leukocyte Telomere Length, study by study

1 effect with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.

Each row is one study: what was changed, the effect it reported on this marker, and the source.
TypeInterventionReported effectEvidenceSource
supplementVitamin D3 2000 IU daily for 4 years in US adults (women >=55, men >=50)Vitamin D3 reduced leukocyte telomere attrition by 0.14 kb (95% CI 0.007-0.27) over 4 years vs placebo (~0.035 kb/year)RCTZhu H, Manson JE, Cook NR, et al. Vitamin D3 and marine omega-3 fatty acids…

What else moves this marker

They describe those study groups, not an individual, and an association is not a cause.

Diseases and conditions

Each row is one study: what it compared and the change it reported in this marker.
WhatEffect on the markerComparison · populationSource
↓ Alzheimer's disease · AD patients vs controlsSMD -0.7 (95% CI -0.95 to -0.46)AD patients vs controls · 30 telomere-length datasets; 2248 AD patients, 4865 controlsmeta analysis · PMID 34654043
↓ Bipolar disorder · bipolar disorder patients vs healthy controlsSMD +0.18 (95% CI -0.04 to 0.39)bipolar disorder vs healthy controls (shorter telomeres in patients) · 19 observational studies in meta-analysis; bipolar patients vs healthy controlsmeta analysis · PMID 40209537
↑ Polycystic ovary syndrome · non-pregnant women with vs without PCOSSMD +0.25 (95% CI -0.01 to 0.51)PCOS vs controls (leukocyte telomere length) · 6 studies; 1155 women with PCOS, 954 withoutmeta analysis · PMID 35254177
↓ Schizophrenia · schizophrenia patients vs healthy controlsSMD +0.35 (95% CI 0.11 to 0.6)schizophrenia vs healthy controls (shorter telomeres in patients) · 19 observational studies in meta-analysis; schizophrenia/bipolar patients vs healthy controlsmeta analysis · PMID 40209537